Search research articles
Contact Us
Filters
Showing results (61-70 of 119) with videos related to
Page
of 12
Sort By:
Frontiers in Immunology
|
October 14, 2024
Lanadelumab in a kidney transplant patient with hereditary angioedema due to C1-inhibitor deficiency and high cardiovascular risk - a case report
Antonio Gidaro, Leyla La Cava, Mattia Donadoni, et al.
International Archives of Allergy and Immunology
|
June 27, 2015
Treatment of HAE Attacks in the Icatibant Outcome Survey: An Analysis of Icatibant Self-Administration versus Administration by Health Care Professionals
Dolores Hernández Fernandez de Rojas, Ethel Ibañez, Hilary Longhurst, et al.
Orphanet Journal of Rare Diseases
|
January 10, 2021
Psychological processes in the experience of hereditary angioedema in adult patients: an observational study
Livia Savarese, Maria Bova, Assunta Maiello, et al.
Clinical and Translational Allergy
|
July 31, 2019
Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey
Anette Bygum, Teresa Caballero, Anete S Grumach, et al.
Plos One
|
November 7, 2017
Hereditary angioedema: Assessing the hypothesis for underlying autonomic dysfunction
Maddalena A Wu, Francesco Casella, Francesca Perego, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
September 1, 2018
Pediatricians diagnosed few patients with childhood-presented hereditary angioedema: Icatibant Outcome Survey findings
Anete S Grumach, Hilary J Longhurst, Werner Aberer, et al.
Health and Quality of Life Outcomes
|
February 13, 2025
A COSMIN systematic review of instruments for evaluating health-related quality of life in people with Hereditary Angioedema
Irene Baroni, Giulia Paglione, Giada De Angeli, et al.
Frontiers in Immunology
|
March 2, 2026
A Treat-to-Target approach in hereditary angioedema: expert consensus from a European committee
Mauro Cancian, Teresa Caballero, Isabelle Boccon-Gibod, et al.
Clinical and Translational Allergy
|
October 20, 2018
Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey
Andrea Zanichelli, Markus Magerl, Hilary J Longhurst, et al.
Frontiers in Immunology
|
June 1, 2026
Angioedema due to acquired C1 inhibitor deficiency: patient experience, conceptual disease model, and assessment of patient-reported outcome measures
Mats de Lange, Danny M Cohn, Delphine Gobert, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 119) with videos related to
Sort By:
Page
of 12
Frontiers in Immunology
|
October 14, 2024
Lanadelumab in a kidney transplant patient with hereditary angioedema due to C1-inhibitor deficiency and high cardiovascular risk - a case report
Antonio Gidaro, Leyla La Cava, Mattia Donadoni, et al.
International Archives of Allergy and Immunology
|
June 27, 2015
Treatment of HAE Attacks in the Icatibant Outcome Survey: An Analysis of Icatibant Self-Administration versus Administration by Health Care Professionals
Dolores Hernández Fernandez de Rojas, Ethel Ibañez, Hilary Longhurst, et al.
Orphanet Journal of Rare Diseases
|
January 10, 2021
Psychological processes in the experience of hereditary angioedema in adult patients: an observational study
Livia Savarese, Maria Bova, Assunta Maiello, et al.
Clinical and Translational Allergy
|
July 31, 2019
Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey
Anette Bygum, Teresa Caballero, Anete S Grumach, et al.
Plos One
|
November 7, 2017
Hereditary angioedema: Assessing the hypothesis for underlying autonomic dysfunction
Maddalena A Wu, Francesco Casella, Francesca Perego, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
September 1, 2018
Pediatricians diagnosed few patients with childhood-presented hereditary angioedema: Icatibant Outcome Survey findings
Anete S Grumach, Hilary J Longhurst, Werner Aberer, et al.
Health and Quality of Life Outcomes
|
February 13, 2025
A COSMIN systematic review of instruments for evaluating health-related quality of life in people with Hereditary Angioedema
Irene Baroni, Giulia Paglione, Giada De Angeli, et al.
Frontiers in Immunology
|
March 2, 2026
A Treat-to-Target approach in hereditary angioedema: expert consensus from a European committee
Mauro Cancian, Teresa Caballero, Isabelle Boccon-Gibod, et al.
Clinical and Translational Allergy
|
October 20, 2018
Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey
Andrea Zanichelli, Markus Magerl, Hilary J Longhurst, et al.
Frontiers in Immunology
|
June 1, 2026
Angioedema due to acquired C1 inhibitor deficiency: patient experience, conceptual disease model, and assessment of patient-reported outcome measures
Mats de Lange, Danny M Cohn, Delphine Gobert, et al.
Page
of 12